Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yousef Al-Abed

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
Drug Discovery Today|September 27, 2016
The challenges of modulating the 'rest and digest' system: acetylcholine receptors as drug targetsSonya VanPatten, Yousef Al-Abed
Future Medicinal Chemistry|March 25, 2011
MIF as a disease target: ISO-1 as a proof-of-concept therapeuticYousef Al-Abed, Sonya VanPatten
Journal of Neuroinflammation|January 23, 2014
MIF: mood improving/inhibiting factor?Joshua Bloom, Yousef Al-Abed
Journal of Medicinal Chemistry|December 22, 2017
High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug TargetSonya VanPatten, Yousef Al-Abed
Bioorganic & Medicinal Chemistry Letters|May 10, 2006
Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activityKai Fan Cheng, Yousef Al-Abed
Expert Opinion on Therapeutic Targets|November 2, 2016
MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug developmentJoshua Bloom, Shan Sun, Yousef Al-Abed
Journal of Biomolecular Structure & Dynamics|September 22, 2018
Mechanistic insights into high mobility group box-1 (HMGb1)-induced Toll-like receptor 4 (TLR4) dimer formationShan Sun, Mingzhu He, Sonya VanPatten, et al.
Journal of Neuroinflammation|April 19, 2015
Rodent models of neuroinflammation for Alzheimer's diseaseAmir Nazem, Roman Sankowski, Michael Bacher, et al.
Current Medicinal Chemistry|May 11, 2022
Azapeptides -A History of Synthetic Milestones and Key ExamplesKai Fan Cheng, Sonya VanPatten, Mingzhu He, et al.
Molecular Medicine (Cambridge, Mass.)|November 10, 2020
SARS-CoV-2 and interferon blockadeBetty Diamond, Bruce T Volpe, Sonya VanPatten, et al.
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Drug Discovery Today|September 27, 2016
The challenges of modulating the 'rest and digest' system: acetylcholine receptors as drug targetsSonya VanPatten, Yousef Al-Abed
Future Medicinal Chemistry|March 25, 2011
MIF as a disease target: ISO-1 as a proof-of-concept therapeuticYousef Al-Abed, Sonya VanPatten
Journal of Neuroinflammation|January 23, 2014
MIF: mood improving/inhibiting factor?Joshua Bloom, Yousef Al-Abed
Journal of Medicinal Chemistry|December 22, 2017
High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug TargetSonya VanPatten, Yousef Al-Abed
Bioorganic & Medicinal Chemistry Letters|May 10, 2006
Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activityKai Fan Cheng, Yousef Al-Abed
Expert Opinion on Therapeutic Targets|November 2, 2016
MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug developmentJoshua Bloom, Shan Sun, Yousef Al-Abed
Journal of Biomolecular Structure & Dynamics|September 22, 2018
Mechanistic insights into high mobility group box-1 (HMGb1)-induced Toll-like receptor 4 (TLR4) dimer formationShan Sun, Mingzhu He, Sonya VanPatten, et al.
Journal of Neuroinflammation|April 19, 2015
Rodent models of neuroinflammation for Alzheimer's diseaseAmir Nazem, Roman Sankowski, Michael Bacher, et al.
Current Medicinal Chemistry|May 11, 2022
Azapeptides -A History of Synthetic Milestones and Key ExamplesKai Fan Cheng, Sonya VanPatten, Mingzhu He, et al.
Molecular Medicine (Cambridge, Mass.)|November 10, 2020
SARS-CoV-2 and interferon blockadeBetty Diamond, Bruce T Volpe, Sonya VanPatten, et al.
Pageof 18